ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1677

$1.24M Total Retail Price of All Prescriptions

Rank: 38 out of 1677

324 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 324 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

39% of this provider’s 324 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 23,552 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

77 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
TRAZODONE HCL 1,485 1,426 1 37
FAMOTIDINE 1,107 1,084 10 2 41
HYDROCODONE-ACETAMINOPHEN 1,071 1,024 S3 3 4
FUROSEMIDE 1,049 1,024 4 8
LISINOPRIL 950 904 5 3
AMLODIPINE BESYLATE 823 816 6 2
LEVOTHYROXINE SODIUM 817 795 7 5
NAMENDA 780 775 8 39
MIRTAZAPINE 669 647 9 62
WARFARIN SODIUM 627 627 10 24
POTASSIUM CHLORIDE 607 581 11 14
SERTRALINE HCL 603 567 12 26
RISPERIDONE 511 428 13 60
METOPROLOL TARTRATE 507 489 14 12
DONEPEZIL HCL 506 506 15 30
OMEPRAZOLE 440 407 16 6
SIMVASTATIN 416 398 17 1
TRAMADOL HCL 403 376 18 16
CITALOPRAM HBR 402 397 19 22
GABAPENTIN 319 319 20 11
CLOPIDOGREL 276 253 21 32
BUPROPION HCL 262 262 10 22 247
ISOSORBIDE MONONITRATE ER 256 256 23 73
CARVEDILOL 248 238 24 20
QUETIAPINE FUMARATE 240 230 25 77
LANTUS 235 202 26 44
LIDODERM 206 206 27 160
EXELON 194 194 28 119
CYMBALTA 192 192 29 58
ALBUTEROL SULFATE 190 187 30 135
LEVOFLOXACIN 186 179 31 84
IPRATROPIUM BROMIDE 184 183 32 171
PLAVIX 178 170 33 47
METFORMIN HCL 173 152 34 7
ATENOLOL 163 163 35 21
DIVALPROEX SODIUM 148 110 36 111
GLIPIZIDE ER 144 144 37 78
METOPROLOL SUCCINATE 144 142 37 23
LEVETIRACETAM 137 85 39 116
HYDROCHLOROTHIAZIDE 136 136 40 9
ADVAIR DISKUS 131 131 41 54
SEROQUEL 129 122 42 151
HYDRALAZINE HCL 127 127 43 69
LATANOPROST 124 124 44 204
METOCLOPRAMIDE HCL 124 109 44 124
PRAVASTATIN SODIUM 119 119 46 10
NEXIUM 113 97 47 19
LANTUS SOLOSTAR 111 111 48 132
DIGOXIN 107 107 49 71
ADVAIR HFA 106 88 50 258
AMIODARONE HCL 102 102 51 249
NOVOLIN R 99 86 52 133
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 92 53 85
TORSEMIDE 90 90 54 152
SPIRIVA 83 77 55 74
SPIRONOLACTONE 83 68 55 88
BENAZEPRIL HCL 79 79 57 53
FOSINOPRIL SODIUM 77 77 58 221
TIMOLOL MALEATE 76 76 59 320
PHENYTOIN SODIUM EXTENDED 76 63 59 112
DOXYCYCLINE HYCLATE 76 76 59 96
CEPHALEXIN 74 67 62 99
NITROGLYCERIN PATCH 68 68 63 184
AGGRENOX 65 65 64 191
KETOCONAZOLE 65 53 64 244
AMOXICILLIN 64 59 66 94
NIFEDIPINE ER 64 64 66 98
CARBIDOPA-LEVODOPA 64 64 66 131
NUEDEXTA 62 62 69 241
RANEXA 61 61 70 396
CIPROFLOXACIN HCL 59 53 71 57
ESCITALOPRAM OXALATE 59 59 71 80
DILTIAZEM 24HR ER 57 57 73 144
GLIPIZIDE 56 56 74 56
SUCRALFATE 55 53 75 146
CLOTRIMAZOLE-BETAMETHASONE 54 51 76 166
HUMALOG 54 54 76 224
CARBAMAZEPINE 53 24 78 230
PREDNISONE 52 52 79 40
TRAVATAN Z 52 52 79 231
AZITHROMYCIN 51 46 81 38
CHLORHEXIDINE GLUCONATE 50 49 82 370
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.